Axsome Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Axsome Therapeutics using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-03 | $-0.68 | $-0.87 | 21.8 % |
| Q2 | 2025-08-04 | $-0.47 | $-1.05 | 55.7 % |
| Q1 | 2025-05-05 | $-0.68 | $-1.35 | 49.6 % |
| Q4 | 2025-02-18 | $-0.80 | $-0.99 | 19.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-03 | $170.99M | $163.41M | 4.64 % |
| Q2 | 2025-08-04 | $150.04M | $138.65M | 7.86 % |
| Q1 | 2025-05-05 | $121.46M | $119.28M | 1.83 % |
| Q4 | 2025-02-18 | $118.77M | $117.83M | 0.79 % |
Axsome Therapeutics (AXSM) is scheduled to report earnings on February 17, 2026. The last reported earnings were for reported on November 3, 2025 for Q3.
The Actual EPS was $-0.68, which beat the estimate of $-0.87.
The Actual Revenue was $171M, which beat the estimate of $163.4M.
Browse earnings estimates, EPS, and revenue on all stocks.